Junyong Weng

1.2k total citations · 1 hit paper
29 papers, 834 citations indexed

About

Junyong Weng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junyong Weng has authored 29 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Junyong Weng's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Junyong Weng is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). Junyong Weng collaborates with scholars based in China, Sweden and Germany. Junyong Weng's co-authors include Zhonglin Zhu, Shanbao Li, Yufei Yang, Ruoxin Zhang, Qi Liu, Xinxiang Li, Qiuyan Zhao, Yugang Wen, Yushuai Mi and Senlin Zhao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Carcinogenesis.

In The Last Decade

Junyong Weng

27 papers receiving 829 citations

Hit Papers

Exploring immunotherapy in colorectal cancer 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyong Weng China 14 514 373 249 144 95 29 834
Lu Zang China 12 716 1.4× 448 1.2× 216 0.9× 111 0.8× 81 0.9× 26 923
Shucai Yang China 13 509 1.0× 317 0.8× 230 0.9× 95 0.7× 154 1.6× 24 793
Longchang Jiang Germany 8 674 1.3× 622 1.7× 350 1.4× 102 0.7× 139 1.5× 14 1.1k
Qingchao Tang China 17 524 1.0× 410 1.1× 277 1.1× 117 0.8× 46 0.5× 47 871
Xiaohui Pan China 16 517 1.0× 306 0.8× 217 0.9× 109 0.8× 188 2.0× 27 853
Yoon‐Kyung Jeon South Korea 15 511 1.0× 285 0.8× 323 1.3× 290 2.0× 125 1.3× 16 904
Yueling Liao China 16 425 0.8× 206 0.6× 234 0.9× 131 0.9× 121 1.3× 25 710
Shangke Huang China 13 421 0.8× 244 0.7× 274 1.1× 69 0.5× 110 1.2× 28 743
Zhongtao Zhang China 17 569 1.1× 480 1.3× 193 0.8× 125 0.9× 73 0.8× 44 906
Xiaobo Cui China 18 574 1.1× 319 0.9× 210 0.8× 66 0.5× 66 0.7× 49 864

Countries citing papers authored by Junyong Weng

Since Specialization
Citations

This map shows the geographic impact of Junyong Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyong Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyong Weng more than expected).

Fields of papers citing papers by Junyong Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyong Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyong Weng. The network helps show where Junyong Weng may publish in the future.

Co-authorship network of co-authors of Junyong Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Junyong Weng. A scholar is included among the top collaborators of Junyong Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyong Weng. Junyong Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shanbao, Junyong Weng, Jing Lu, et al.. (2025). TDO2 Deficiency Exacerbates the Immune Rejection Response in Rat Liver Transplantation via the Kyn-AHR Axis. Transplantation. 109(8). e386–e399.
3.
Weng, Junyong, et al.. (2024). The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis. Cellular & Molecular Biology Letters. 29(1). 144–144. 3 indexed citations
4.
5.
Liu, Qi, Yajuan Zhang, Huimin Li, et al.. (2024). Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling. 22(1). 278–278. 8 indexed citations
6.
Zhu, Zhonglin, et al.. (2024). LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3. Cancer Letters. 589. 216828–216828. 7 indexed citations
8.
Li, Shanbao, Junyong Weng, Chao Xiao, et al.. (2023). Cuproptosis‐related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features. Cancer Reports. 6(12). e1904–e1904. 6 indexed citations
9.
Yang, Yufei, Dakui Luo, Yang Shao, et al.. (2022). circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer. Cancer Communications. 43(1). 100–122. 46 indexed citations
10.
Zhu, Zhonglin, Qiuyan Zhao, Junyong Weng, et al.. (2022). A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer. Frontiers in Immunology. 13. 940774–940774. 39 indexed citations
11.
Weng, Junyong, Shanbao Li, Zhonglin Zhu, et al.. (2022). Exploring immunotherapy in colorectal cancer. Journal of Hematology & Oncology. 15(1). 95–95. 219 indexed citations breakdown →
12.
Li, Shanbao, Lei Li, Fangbin Song, et al.. (2020). <p>TDO Promotes Hepatocellular Carcinoma Progression</p>. OncoTargets and Therapy. Volume 13. 5845–5855. 24 indexed citations
13.
Li, Shanbao, Junyong Weng, Fangbin Song, et al.. (2020). Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. Cell Death and Disease. 11(6). 452–452. 37 indexed citations
14.
Xiao, Jingbo, Junyong Weng, Yangyang Hu, Guilong Deng, & Xinjian Wan. (2020). Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma. World Journal of Gastroenterology. 26(31). 4589–4606. 14 indexed citations
15.
Xiao, Chao, Gang Wu, Zhijie Zhou, et al.. (2019). RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer. Cell Death and Disease. 10(11). 833–833. 31 indexed citations
16.
Qin, Zhiwei, Zhengqian Chen, Junyong Weng, et al.. (2019). <p>Elevated <em>HOXA13</em> expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2</p>. OncoTargets and Therapy. Volume 12. 1803–1813. 17 indexed citations
17.
Li, Shanbao, Junyong Weng, Lei Li, et al.. (2019). Circular RNA circZNF566 Promotes Hepatocellular Carcinoma Progression by Sponging miR-4738-3p and Regulating TDO2 Expression. SSRN Electronic Journal. 2 indexed citations
18.
Weng, Junyong, Jingbo Xiao, Yushuai Mi, et al.. (2018). PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer. Cell Death and Disease. 9(2). 27–27. 41 indexed citations
19.
Li, Tianyi, Bin Yan, Yang Ma, et al.. (2018). Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination. Cell Death and Disease. 9(2). 148–148. 40 indexed citations
20.
Zhao, Qiuyan, Sumin Chen, Zhonglin Zhu, et al.. (2018). miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2. Cell Death and Disease. 9(12). 1157–1157. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026